从2015美国糖尿病协会《糖尿病医学诊疗标准》看降糖药物治疗新进展

被引:11
作者
陆菊明
机构
[1] 解放军总医院内分泌科
关键词
糖尿病; 糖尿病医学诊疗标准; 药物治疗;
D O I
暂无
中图分类号
R587.1 [糖尿病];
学科分类号
100201 [内科学];
摘要
美国糖尿病协会发表的2015《糖尿病医学诊疗标准》在2014版的基础上根据糖尿病领域最新的和最受关注的研究进展结果进行了修改。笔者将对该版诊疗标准中降糖药物治疗的更新内容做一简要解读,以便临床医师、药师了解2型糖尿病药物治疗的最新进展,对临床工作有所助益。
引用
收藏
页码:1 / 4
页数:4
相关论文
共 6 条
[1]
Comparison of the effects on glycaemic control and β-cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel-group trial (the CONFIDENCE study) [J].
Xu, W. ;
Bi, Y. ;
Sun, Z. ;
Li, J. ;
Guo, L. ;
Yang, T. ;
Wu, G. ;
Shi, L. ;
Feng, Z. ;
Qiu, L. ;
Li, Q. ;
Guo, X. ;
Luo, Z. ;
Lu, J. ;
Shan, Z. ;
Yang, W. ;
Ji, Q. ;
Yan, L. ;
Li, H. ;
Yu, X. ;
Li, S. ;
Zhou, Z. ;
Lv, X. ;
Liang, Z. ;
Lin, S. ;
Zeng, L. ;
Yan, J. ;
Ji, L. ;
Weng, J. .
JOURNAL OF INTERNAL MEDICINE, 2015, 277 (01) :137-150
[2]
Baseline glycemic parameters predict the hemoglobin A 1c response to DPP-4 inhibitors.[J].Katherine Esposito;Paolo Chiodini;Annalisa Capuano;Maria Ida Maiorino;Giuseppe Bellastella;Dario Giugliano.Endocrine.2014, 1
[3]
Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes.[J].Guillermo E. Umpierrez;Roma Gianchandani;Dawn Smiley;Sol Jacobs;David H. Wesorick;Christopher Newton;Farnoosh Farrokhi;Limin Peng;David Reyes;Sangeeta Lathkar-Pradhan;Francisco Pasquel.Diabetes Care.2013, 11
[4]
Gliptin versus a sulphonylurea as add-on to metformin [J].
Scheen, Andre J. ;
Paquot, Nicolas .
LANCET, 2012, 380 (9840) :450-452
[5]
Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis [J].
Liu, S. -C. ;
Tu, Y. -K. ;
Chien, M. -N. ;
Chien, K. -L. .
DIABETES OBESITY & METABOLISM, 2012, 14 (09) :810-820
[6]
Dipeptidyl peptidase‐4 inhibitors in the treatment of type 2 diabetes: a comparative review.[J].C. F.Deacon.Diabetes; Obesity and Metabolism.2010, 1